| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
245 |
203 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
93 |
59 |
$414.13 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
83 |
75 |
$73.19 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
136 |
107 |
$51.78 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
135 |
106 |
$51.78 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25 |
15 |
$33.20 |
| 80053 |
Comprehensive metabolic panel |
246 |
208 |
$31.68 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
115 |
98 |
$25.18 |
| 84443 |
Thyroid stimulating hormone (TSH) |
68 |
54 |
$14.56 |
| 80061 |
Lipid panel |
221 |
190 |
$13.39 |
| 86803 |
|
61 |
56 |
$10.10 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
139 |
118 |
$9.71 |
| 87070 |
|
15 |
14 |
$7.46 |
| 86592 |
|
15 |
13 |
$3.30 |
| 85027 |
|
75 |
58 |
$3.20 |
| 84439 |
|
17 |
12 |
$0.00 |
| 85018 |
|
25 |
13 |
$0.00 |